Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Shares Gap Up – Here’s What Happened

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) gapped up prior to trading on Monday. The stock had previously closed at $12.30, but opened at $12.72. Bayer Aktiengesellschaft shares last traded at $12.71, with a volume of 50,995 shares trading hands.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Zacks Research upgraded Bayer Aktiengesellschaft from a “hold” rating to a “strong-buy” rating in a report on Friday, July 10th. Deutsche Bank Aktiengesellschaft upgraded shares of Bayer Aktiengesellschaft from a “hold” rating to a “buy” rating in a report on Thursday, July 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, Bayer Aktiengesellschaft presently has an average rating of “Buy”.

Bayer Aktiengesellschaft Stock Performance

The firm has a market cap of $49.83 billion, a price-to-earnings ratio of -24.86, a price-to-earnings-growth ratio of 1.86 and a beta of 0.57. The company has a quick ratio of 0.67, a current ratio of 1.04 and a debt-to-equity ratio of 1.05. The stock has a fifty day moving average price of $13.53 and a 200-day moving average price of $12.64.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.29 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.23 by $0.06. The business had revenue of $12.53 billion for the quarter, compared to analyst estimates of $12.31 billion. Bayer Aktiengesellschaft had a negative net margin of 3.80% and a positive return on equity of 16.77%. Bayer Aktiengesellschaft has set its FY 2026 guidance at 1.200-1.346 EPS. On average, analysts expect that Bayer Aktiengesellschaft will post 1.27 earnings per share for the current fiscal year.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft is a Germany-based life sciences company headquartered in Leverkusen. Founded in 1863 by Friedrich Bayer and Johann Friedrich Weskott, the company develops products in health care and agriculture and serves customers in markets around the world.

Bayer operates through three primary businesses: Pharmaceuticals, Consumer Health and Crop Science. Its Pharmaceuticals segment develops prescription medicines in areas such as cardiovascular disease, women’s health, oncology, hematology and specialty therapies.